Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amadori, A.
Right arrow Articles by Amadori, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amadori, A.
Right arrow Articles by Amadori, D.
Related Collections
Right arrow Surgery
Annals of Surgical Oncology 8:723-728 (2001)
© 2001 Society of Surgical Oncology


ORIGINAL ARTICLES

Frequency and Determinants of Lymphadenectomy in Endometrial Carcinoma: A Population-Based Study From Northern Italy

Andrea Amadori, MD, Lauro Bucchi, MD, Gianfranco Gori, MD, Fabio Falcini, MD, Luca Saragoni, MD and Dino Amadori, MD

From the Departments of Obstetrics and Gynecology (AA, GG), Medical Oncology (FF, DA), and Pathology (LS) and the Romagna Cancer Registry (LB), Luigi Pierantoni Hospital, Forlì, Italy.

Correspondence: Address correspondence and reprint requests to: Lauro Bucchi, MD, Romagna Cancer Registry, Medical Oncology Department, Luigi Pierantoni Hospital, 47100 Forlì, Italy; Fax: 039-0543-731-736; E-mail: i.o.r{at}fo.nettuno.it


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Background: The diffusion of pelvic and para-aortic lymphadenectomy for the surgical pathological staging of endometrial carcinoma into clinical practice has been evaluated only with questionnaire surveys of gynecological oncologists. No population-based information is available.

Methods: In this study of operable endometrial carcinoma cases registered by the population-based Romagna Cancer Registry (northern Italy) between 1987 and 1994, the association of demographic (age, time period, place of birth, place of residence, place of treatment, and marital status) and pathological factors (histological type, tumor grade, myoinvasion, and extension of disease to cervix, serosa, adnexa, and vagina) with the probability of lymphadenectomy was evaluated by multiple logistic regression analysis.

Results: Of the 300 potentially eligible cases, sufficient information was obtained for 276 (92%; median age, 63 years; range, 33–87 years). No case of para-aortic lymphadenectomy was observed. Pelvic lymphadenectomy was performed in 86 (31%) cases. The probability of pelvic lymphadenectomy was related to tumor grade (positive association), place of treatment, and marital status. All other variables, including myoinvasion and extension of disease to the cervix and beyond the uterus, had no effect whatsoever.

Conclusions: The most likely interpretations of results include poor acceptance of current surgical pathological staging criteria and insufficient use of standard diagnostic techniques for preoperative and intraoperative assessment of myoinvasion and extrauterine spread.

Key Words: Endometrial carcinoma • Staging • Lymphadenectomy • Tumor grade • Myoinvasion


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The inclusion of pelvic and para-aortic lymph node sampling or dissection in the surgical pathological staging of endometrial carcinoma (EC) as developed in 1988 by the International Federation of Gynecology and Obstetrics (FIGO)1 is still a topic of great controversy. Many experts consider the complete evaluation of pelvic and para-aortic lymph node status as a mandatory criterion.25 Others have questioned the clinical utility of lymphadenectomy in certain subsets of diseases at low risk of nodal involvement, such as those characterized by grade 1 with invasion of two thirds or less of the myometrium,6 grade 1 irrespective of clinical stage,7 and clinical stage I irrespective of grade.8 For opposite reasons, it has been suggested that lymphadenectomy is not justified among high-risk patients who require postoperative irradiation irrespective of nodal status, such as those with stage II disease.9 Moreover, some authors have recommended pelvic node sampling alone10 or pelvic sampling only in the case of grossly enlarged nodes.

It is conceivable that such controversies may adversely affect the translation of the new FIGO criteria to clinical practice. Many reports have shown that lymphadenectomy is a viable and customary procedure at highly specialized centers. In contrast, little is known of the management of EC patients on a large scale. Available data have been obtained with questionnaire surveys.1114 These have shown that tumor grade and myometrial invasion influence the frequency of lymphadenectomy. Such investigations, however, have generally targeted selected categories of professionals or leading centers for gynecological oncology. To the best of our knowledge, the question of lymphadenectomy has never been the subject of a population-based study.

At the cancer registry that covers the Romagna region of northern Italy (Romagna Cancer Registry, RTRO), we retrieved surgical and pathological information on a series of EC cases. Our aim was to evaluate the patterns and correlates of staging and the prognostic value of stage and other known or suspected predictors of survival. This article focuses on the frequency and determinants of lymphadenectomy.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Case Series
Study cases were abstracted from the computerized database of the RTRO. Methods, organization, and incidence data of the registry are reported in detail elsewhere.15 Between 1989 and 1992, the average annual age-standardized (world standard population) incidence rate of cancer of the corpus uteri in the Romagna region was 11.7 per 100,000 women. In the area, a gynecological oncology service is normally provided by the obstetrics and gynecology departments of local public hospitals. Specific hospital departments dedicated to gynecological oncology can be found in distant cities of northern Italy.

In 1999, a computer file was obtained from the RTRO database that included all cases (n = 377) that met the following requirements: (1) topography code 182 (corpus uteri), behavior code 3 (malignant, primary site), and morphology codes 8010 to 8572 (adenocarcinoma and other specified carcinoma types) according to the International Classification of Diseases for Oncology (ICD-O)16; (2) certainty of diagnosis according to standard criteria of cancer registration17; (3) availability of information other than death certificate only; and (4) residence in the districts of Forlì, Ravenna, and Faenza (total female population 219,567 on December 31, 1994). The date of diagnosis varied from 1987 (the first year of cancer registration in Romagna) to 1994 (the most recent year of complete registration available when the study was undertaken).

Items of Information
The computer file comprised all routine registration variables.17 Among these, the following were used for this analysis: date of birth, place of birth, municipality of residence, marital status, date of diagnosis, modalities of diagnosis (histology, surgery, peritoneal cytology, and others), place (hospital and department) of primary surgical treatment, tumor grade, and morphology code according to ICD-O.

Information regarding surgical treatment and stage—routinely collected but not computerized—was abstracted by one of us (A.A.) from the original clinical and histological reports stored in the paper archives of the registry. Patients undergoing hysterectomy with or without salpingo-oophorectomy were considered surgically treated. Lesions reported to invade the middle third of the myometrium were recorded as such. All other stage data were classified according to tumor, node, metastasis/FIGO criteria. The number of pelvic and para-aortic lymph nodes dissected was recorded. Lymphadenectomy was defined as the removal of at least one lymph node. For 48 of 377 (13%) cases, the available data were considered inconclusive or incomplete, thus prompting further inquiries at the referral hospitals.

Elegibility
On the basis of data collected, 77 patients were excluded from the study. These were accounted for by patients not treated surgically (n = 65), patients with surgical FIGO stage IV (n = 7), and patients with T0 disease according to tumor, node, metastasis staging (no evidence of primary tumor on hysterectomy after the diagnosis of EC on biopsy; n = 5). There were thus 300 potentially eligible cases. Adequate information regarding stage parameters and lymphadenectomy was available for 276 (92%) patients. These were included in data analysis.

Objectives and Rationale
Our primary objective was to determine whether factors listed in Table 1 influenced the probability of pelvic lymphadenectomy, para-aortic lymphadenectomy, or both. Major factors included tumor grade and two indicators of disease spread, namely, the depth of myometrial invasion (IA–IB, IC) irrespective of invasion of the cervix or extension beyond the uterus (hereby referred to as myoinvasion) and extension of disease (I, II–IIIA–IIIB) irrespective of lymph node status (hereby referred to as extension). The rationale for such definitions was to obtain two distinct indicators of tumor spread as potentially resulting from preoperative and intraoperative assessment. On the basis of reported data on the relationship between depth of muscle invasion and risk of node metastasis,6 lesions reported to invade the middle third of the myometrium were coded as IB. The secondary aim of the study was to determine the number of lymph nodes dissected and the frequency of nodal involvement.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Factors studied as potential determinants of lymphadenectomy in endometrial carcinoma
 

Data Analysis
Univariate associations were evaluated with the {chi}2 test. Multivariate associations were evaluated with the multiple regression analysis by using a backward stepwise approach. Two separate multiple logistic models were built. Model 1 included myoinvasion and grade, as well as a term for the myoinvasion x grade interaction. Model 2 included extension and grade, as well as a term for the extension x grade interaction. All other factors listed in Table 1 (i.e., histological type, patient age, time period, place of birth, place of residence, place of treatment, and marital status) were included in both models. Age was treated as a continuous variable. Covariates were removed from each model at a level of significance of P > .05. Odds ratios not including the unity were considered statistically significant.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The right column in Table 1 shows the distribution of the 276 cases according to the variables under study. The patient age varied from 33 to 87 years (median, 63 years). A total of 206 patients (75%) were treated in public hospitals located in the study area. Of these, 199 (97%) were treated in general obstetrics and gynecology departments and 7 in general surgery departments. As shown in Table 2, pelvic lymphadenectomy was performed in 31% of the cases. No case of para-aortic lymphadenectomy was observed.


View this table:
[in this window]
[in a new window]
 
TABLE 2. Frequency and results of lymphadenectomy
 

Table 3 shows the results of the two logistic models. In model 1, myoinvasion did not influence the probability of pelvic lymphadenectomy. This was strongly and linearly associated with tumor grade. Also, major differences were related to the place of treatment. At one of three hospitals of the study area, as well as in the private sector, lymphadenectomy was performed in a negligible proportion of cases. It is noteworthy that a two-thirds reduction in the probability of lymphadenectomy was observed among the 32 patients treated in surgical centers situated elsewhere in northern Italy (only one at a leading institution for gynecological oncology). Finally, a significant association with marital status was observed. Histological type, patient age, time period, place of birth, and place of residence exerted no independent effect. No myoinvasion x grade interaction was demonstrated.


View this table:
[in this window]
[in a new window]
 
TABLE 3. Factors significantly associated with the probability of lymphadenectomy as estimated in two separate multiple logistic regression models
 

In model 2, myoinvasion was replaced by extension, and the extension x grade interaction was evaluated. The results were exactly the same as those of model 1. Extension had no effect on the probability of lymphadenectomy, nor did it interact with grade.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
This study from Italy considered the overall frequency and the determinants of lymphadenectomy in a population-based series of EC cases. For both end points, the results can be compared with those of questionnaire surveys of gynecological oncologists.1114 In the United States,12 27%, 68%, and 90% of respondents indicated that they performed lymphadenectomy in >75% of tumors with grade 1, 2, and 3, respectively. Para-aortic lymphadenectomy was performed by 12% of respondents for grade 1 cases limited to the endometrium and by 96% for grade 3 cases with deep myoinvasion. In most centers surveyed in Europe, the surgical pathological staging seemed to be less widely practiced. Lymphadenectomy not otherwise specified was performed only for severe conditions such as grade 3, deep myoinvasion, and grossly enlarged nodes.11 This seems to be equivalent to saying that lymphadenectomy was performed in a minority of cases. This study confirmed that situation (Table 1). On average, only 31% of patients underwent pelvic node dissection with a poorer number of nodes than that observed in major series.18,19 No para-aortic lymphadenectomy was performed. Moreover, no positive time trend was observed. However, the probability of lymphadenectomy was not evenly distributed among the hospitals and clinics in the study area. In two major public hospitals, 45% of EC patients underwent pelvic lymphadenectomy (Table 3). In one small public hospital, as well as in the private sector (four small private hospitals with an average of one case of EC surgically treated per year), the frequency decreased to 5% or less. The probability of lymphadenectomy was also poor for those patients who moved to surgical centers situated elsewhere in northern Italy. This suggests that the situation described in this article was not restricted to patients living in Romagna.

As far as the preoperative and intraoperative determinants of lymphadenectomy are concerned, we found a relationship only with tumor grade. Myoinvasion and extension had no influence whatsoever. Although the statistical power of the study was limited, the myoinvasion x grade and extension x grade interactions were evaluated to test the null hypothesis that the effect of both indicators was the same across the tumor grades. The results suggested that this was the case. One further limitation of the study was the arbitrary classification of tumors with invasion of the middle third of the myometrium as IB cases. Thus, model 1 was rebuilt after placing such cases among those coded as IC. No change in results was observed (data not shown). In fact, lymphadenectomy was equally distributed even in the subset of cases reported by using a three-tier classification of myoinvasion (data not shown). In our opinion, such findings were compatible with four essential interpretations not mutually exclusive.

First, one may hypothesize that tumor grade was really considered as the only relevant parameter. If so, such a view is only partially in line with the most widespread concepts regarding lymphadenectomy. Although the value of grade is generally accepted6,12 and particularly emphasized by some authors,7 most European gynecological oncologists stated that they consider myoinvasion as a factor of importance.11 In the United States, myoinvasion has been reported to be a major determinant of lymphadenectomy, especially among grade 1 and 2 tumors.6,12 As has been pointed out, however, continuing controversy about those criteria is expected to adversely affect their acceptance on a large scale, with an inevitable lack of uniformity in surgical management of EC patients.12

Second, the results are compatible with the hypothesis that preoperative assessment of myoinvasion and extrauterine spread was less than optimal. Before the implementation of the new FIGO system, clinical staging was based on the identification of gross invasion of the cervix and positive endocervical curettage.6,20 Over the years, presurgical staging has been improved by accurate pelvic examination, blood tests, pelvic washing, and imaging evaluations of the pelvis and abdomen.3 Among these, transvaginal ultrasonography has been demonstrated to predict the depth of invasion as well as the tumor volume.21 At least in part, our data are likely to reflect insufficient use of such techniques. In particular, transvaginal ultrasonography was still incompletely available during the study period, and the computed tomography services were often saturated.

Third, it cannot be excluded that our results are at least partially related to problems with intraoperative assessment of myometrial invasion. During surgery, this can be determined either grossly, by bivalving the uterus, or on frozen sections.6,22 In the United States, bivalving and gross examination of the uterus have been reported to be an almost customary practice, whereas frozen section analysis is performed in relation to tumor grade.12 In Romagna, no routine information is available. According to personal communications from the pathology departments in the area, both procedures are seldom practiced. It has been suggested that a low frequency of lymphadenectomy may reflect a tendency to individualize surgical staging on the basis of the intraoperative evaluation of the uterine specimen.12 In this case series, lymphadenectomy was infrequent, but no relation with intraoperative parameters was observed. Following this line of reasoning, it is suggested that the strong effect of tumor grade depended only on the availability of that information as reported on biopsy.

Fourth, our observations are likely to suggest that surgical stage information had only a limited effect on treatment planning. Although the frequency of adjuvant therapy was not an end point of the study, we collected data (not shown) for patients living in the district of Forlì (37% of the study population). Among these, only 52% stage IC cases and 44% cases with extrauterine (stage II–III) disease underwent radiotherapy. The frequency of chemotherapy was negligible (3%).

In conclusion, we found that the average frequency of lymphadenectomy was poorer than that expected on the basis of the figures reported from United States and that tumor grade was the only factor taken into consideration. The second part of this study will be aimed at survival analysis. Stage misclassifications possibly related to the observed pattern of surgical management of the disease will be investigated by evaluating the consistency of the stage-specific 5-year survival rates.


    Acknowledgments
 
The authors thank Massimo Giannini, MD, Radiotherapy Department, Luigi Pierantoni Hospital, Forlì, for collaboration. Supported in part by the Istituto Oncologico Romagnolo, Forlì. The Romagna Cancer Registry is funded by the Regione Emilia-Romagna, Bologna, Italy (Deliberazione della Giunta regionale 862/1995).

Received for publication February 15, 2001. Accepted for publication June 20, 2001.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Mikuta JJ. International Federation of Gynecology and Obstetrics staging of endometrial cancer. Cancer 1993; 71: 1460–3.[Medline]
  2. Homesley HD, Zaino R. Endometrial cancer: prognostic factors. Semin Oncol 1994; 21: 71–8.[Medline]
  3. Mikuta JJ. Preoperative evaluation and staging of endometrial cancer. Cancer 1995; 76: 2041–3.[Medline]
  4. Yokoyama Y, Maruyama H, Sato S, Saito Y. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol Oncol 1997; 64: 411–7.[CrossRef][Medline]
  5. Barnes MN, Kilgore LC. Complete surgical staging of early endometrial adenocarcinoma: optimizing patient outcome. Semin Radiat Oncol 2000; 10: 3–7.[Medline]
  6. Creasman WT. Limited disease: role of surgery. Semin Oncol 1994; 21: 79–83.
  7. Geisler JP, Wiemann MC, Zhou Z, Miller GA, Geisler HE. Using FIGO histologic grade to determine when to perform lymphadenectomies in endometrioid adenocarcinoma of the endometrium. Eur J Gynaecol Oncol 1996; 17: 204–7.[Medline]
  8. Belinson JL, Lee KR, Badger GJ, Pretorius RG, Jarrel MA. Clinical stage I adenocarcinoma of the endometrium: analysis of recurrences and the potential benefit of staging lymphadenectomy. Gynecol Oncol 1992; 44: 17–23.[Medline]
  9. Descamps P, Body G, Calais G, et al. Stage I and II endometrial cancer: should lymphadenectomy still be done? J Gynecol Obstet Biol Reprod 1995; 24: 794–801.[Medline]
  10. Faught W, Krepart GV, Lotocki R, Heywood M. Should selective paraaortic lymphadenectomy be part of surgical staging for endometrial cancer? Gynecol Oncol 1994; 55: 51–5.[CrossRef][Medline]
  11. Maggino T, Romagnolo C, Zola P, Sartori E, Landoni F, Gadducci A. An analysis of approaches to the treatment of endometrial cancer in western Europe: a CTF study. Eur J Cancer 1995; 31A: 1993–7.[CrossRef]
  12. Gretz HFIII, Economos K, Husain A, et al. The practice of surgical staging and its impact on adjuvant treatment recommendations in patients with stage I endometrial carcinoma. Gynecol Oncol 1996; 61: 409–15.[Medline]
  13. Maggino T, Romagnolo C, Landoni F, Sartori E, Zola P, Gadducci A. An analysis of approaches to the management of endometrial cancer in North America: a CTF study. Gynecol Oncol 1998; 68: 274–9.[CrossRef][Medline]
  14. Konno R, Sato S, Yajima A. A questionnaire survey on current surgical procedures for endometrial cancer in Japan. Tohoku J Exp Med 2000; 190: 193–203.[Medline]
  15. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents. Vol 7. Lyon: International Agency for Research on Cancer, 1997.
  16. World Health Organization. International Classification of Diseases for Oncology. Geneva: World Health Organization, 1976.
  17. MacLennan R. Items of patient information which may be collected by registries.In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, eds. Cancer Registration: Principles and Methods. Lyon: International Agency for Research on Cancer, 1991: 43–63.
  18. Larson DM, Johnson K, Olson KA. Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer: morbidity and mortality. Obstet Gynecol 1992; 79: 998–1001.[Abstract/Free Full Text]
  19. Wolfson AH, Sightler SE, Markoe AM, et al. The prognostic significance of surgical staging for carcinoma of the endometrium. Gynecol Oncol 1992; 45: 142–6.[Medline]
  20. Creasman WT, DeGeest K, DiSaia PJ, Zaino RJ. Significance of true surgical pathologic staging: a Gynecologic Oncology Group study. Am J Obstet Gynecol 1999; 181: 31–4.[Medline]
  21. Shipley CFIII, Smith ST, Dennis EJIII, Nelson GH. Evaluation of pretreatment transvaginal ultrasonography in the management of patients with endometrial carcinoma. Am J Obstet Gynecol 1992; 167: 406–11.[Medline]
  22. Gusberg SB. Virulence factors in endometrial cancer. Cancer 1993; 71: 1464–6.[Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amadori, A.
Right arrow Articles by Amadori, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amadori, A.
Right arrow Articles by Amadori, D.
Related Collections
Right arrow Surgery


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS